-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Pyrimethamine in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pyrimethamine in Prostate Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pyrimethamine in Prostate Cancer Drug Details: Pyrimethamine (GLG-801) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Pyrimethamine in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pyrimethamine in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pyrimethamine in Triple-Negative Breast Cancer (TNBC) Drug Details: Pyrimethamine (GLG-801)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Pyrimethamine in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pyrimethamine in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pyrimethamine in Non-Small Cell Lung Cancer Drug Details: Pyrimethamine (GLG-801)...
-
Product Insights
Polycystic Kidney Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Polycystic Kidney Disease - Drugs In Development, 2023’, provides an overview of the Polycystic Kidney Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Polycystic Kidney Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Company Profile
GLG Life Tech Corp – Company Profile
GLG Life Tech Corp (GLG) is a vertically integrated producer of zero-calorie natural sweeteners and functional ingredients. The company’s natural sweeteners include high-grade stevia extract and monk fruit extract. It carries out the research and development, growing, refining, and production of these extracts for distribution to the global food and beverage industry. GLG markets its products under Rebpure, Organipure, BlendSure, TasteBoost, Rebsweet, AnySweetPLUS, Pure STV, Monk Gold, and Monk Sweet brand names. It conducts seed and plant development, stevia leaf...
Add to Basket -
Product Insights
GLG Grp – 80 Cecil Street Commercial Precinct – Victoria
Equip yourself with the essential tools needed to make informed and profitable decisions with our GLG Grp - 80 Cecil Street Commercial Precinct - Victoria report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Company Profile
Man Group Plc – Company Profile
Man Group Plc (Man Group) is an alternative investment management company. The company invests through Man AHL, Man Numeric, Man GLG, Man FRM and Man Global Private Markets investment managers, and offers a range of products and services to institutional and private investors in quantitative, discretionary and private markets. These investment managers offer alternative, long-only and private markets strategies across various asset classes such as equity, credit, commodities, currency markets, volatility, multi asset and real estate. Its key offerings include...
Add to Basket -
Product Insights
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Ovarian Cancer Pipeline Products Market Report Overview Ovarian cancer is any cancerous growth that may occur in different parts of the ovary. The majority of ovarian cancers arise from the epithelium (outer lining) of the ovary. Signs and symptoms of ovarian cancer include pelvic discomfort or pain, indigestion, gas or nausea, and changes in bowel habits, such as constipation, loss of appetite, and low back pain. The predisposing factors include age and family history. Treatment includes surgery, chemotherapy, and radiation...
-
Product Insights
Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Colorectal Cancer Pipeline Drugs Market Overview Colorectal cancer starts in the colon or the rectum. It begins as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools, and weight loss with no known reasons. Risk factors for colorectal cancer include smoking, heavy alcohol use, inflammatory bowel disease (IBD), and family history. Treatment includes...
-
Product Insights
Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Non-Small Cell Lung Cancer Pipeline Drugs Market Report Overview Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. NSCLC is a cancer (malignancy) that originates in the tissues of the lungs or the cells lining the airways. Symptoms of lung cancer usually occur in the later stages of the disease. The signs and symptoms include a persistent cough that may get worse over time, trouble breathing or shortness of breath, constant chest pain or discomfort, bloody...